YiChang HEC ChangJiang Pharmaceutical Dividends and Buybacks
Dividend criteria checks 0/6
YiChang HEC ChangJiang Pharmaceutical does not currently pay a dividend.
Key information
0%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 10.9% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | HK$0.400 |
| Payout ratio | 0% |
Recent dividend and buyback updates
No updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 1558's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1558's dividend payments have been increasing.
Dividend Yield vs Market
| YiChang HEC ChangJiang Pharmaceutical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (1558) | 0% |
| Market Bottom 25% (HK) | 3.3% |
| Market Top 25% (HK) | 8.1% |
| Industry Average (Pharmaceuticals) | 3.8% |
| Analyst forecast (1558) (up to 3 years) | 10.9% |
Notable Dividend: Unable to evaluate 1558's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1558's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: 1558 is not paying a notable dividend for the Hong Kong market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 1558 has not reported any payouts.